← Evidence map

ArticlePloS one2017

Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.

Shigeki Saito et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

68 papers cite itlatest 60 shown

2017
…
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 29045477